There is still considerable uncertainty about the place of carotid stenting in patients with recently symptomatic carotid bifurcation stenosis. Most reviews of carotid endarterectomy versus carotid stenting concentrate on technical aspects and advances in stenting, but the techniques involved in both carotid endarterectomy and stenting are evolving. In addition to reviewing the results of the various randomised controlled trials of carotid endarterectomy versus stenting for symptomatic carotid stenosis, this review considers recent advances and current best practice for endarterectomy. Ongoing randomized trials will determine whether or not the procedural risk of stroke and death is definitely lower with endarterectomy than with stenting, but the key issue that remains to be determined reliably is how the procedural risks of stenting vary with patient characteristics – perhaps the most important question being not whether endarterectomy is better than stenting or vice versa, but for whom is one technique likely to be better than the other.

1.
Naylor AR: Surgical controversies; in Chaturvedi S, Rothwell PM (eds): Carotid Artery Stenosis: Current and Emerging Treatments. London, Taylor & Francis, 2005.
2.
Loftus CM, Quest DO: Technical controversies in carotid artery surgery. Neurosurgery 1987;20:490–495.
3.
Darling RC, Paty PSK, Shah DM, Chang BB, Leather RP: Eversion endarterectomy of the internal carotid artery: technique and results in 449 procedures. Surgery 1996;120:635–639.
4.
Cao P, Giordano G, De Rango P, et al, Collaborators of the EVEREST Study Group: A randomised study on eversion versus standard carotid endarterectomy: study design and preliminary results. The Everest Trial. J Vasc Surg 1998;27:595–605.
5.
Cao PG, De Rango P, Zannetti S, et al: Eversion versus conventional carotid endarterectomy for preventing stroke. Cochrane Database Syst Rev 2001;1:CD001921.
6.
Brothers TE: Initial experience with eversion carotid endarterectomy: absence of a learning curve for the first 100 patients. J Vasc Surg 2005;42:429–434.
7.
Frericks H, Kievit J, van Baalen JM, van Bockel JH: Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke 1998;29:244–250.
8.
Hunter GC, Palmaz JC, Hayashi HH, Ravio-la CA, Vogt PJ, Guernsey JM: The aetiology of symptoms in patients with recurrent carotid stenosis. Arch Surg 1987;122:311–315.
9.
Bond R, Rerkasem K, Rothwell PM: Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev 2004;2:CD000160.
10.
Cunningham E, Bond R, Mehta Z, Warlow CP, Rothwell PM: Long-term durability of carotid endarterectomy in the European Carotid Surgery Trial. Stroke 2002;33:2658–2663.
11.
Bond R, Rerkasem K, Rothwell PM: A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 2003;34:2290–2301.
12.
Bond R, Rerkasem K, Naylor R, Abu Rhama A, Rothwell PM: Patches of different types for carotid patch angioplasty. Cochrane Database Syst Rev 2004;2:CD000071.
13.
Naylor AR, Bell PRF, Ruckley CV: Monitoring and cerebral protection during carotid endarterectomy. Br J Surg 1992;79:735–741.
14.
Belardi P, Lucertini G, Ermirio D: Stump pressure and transcranial Doppler for predicting shunting in carotid endarterectomy. Eur J Vasc Endovasc Surg 2003;25:164–167.
15.
Bond R, Warlow CP, Naylor R, Rothwell PM: Variation in surgical and anaesthetic technique and associations with operative risk in the European Carotid Surgery Trial: implications for trials of ancillary techniques. Eur J Vasc Endovasc Surg 2002;23:117–126.
16.
Bond R, Rerkasem K, Rothwell PM: Routine or selective carotid artery shunting for carotid endarterectomy. Cochrane Database Syst Rev 2002;2:CD000190.
17.
Rerkasem K, Bond R, Rothwell PM: Local versus general anaesthetic for carotid endarterectomy. Cochrane Database Syst Rev 2004;2:CD000126.
18.
Kasprzak PM, Altmeppen J, Angerer M, Mann S, Mackh J, Topel I: General versus locoregional anesthesia in carotid surgery: a prospective randomised trial. Vasa 2006;35:232–238.
19.
Naylor AR, Ruckley CV: Complications after carotid surgery; in Campbell B (ed): Complications in Arterial Surgery: A Practical Approach to Management. Oxford, Butterworth-Heinemann, 1996, pp 73–88.
20.
Bond R, Narayan S, Rothwell PM, Warlow CP: Clinical and radiological risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg 2002;23:108–116.
21.
Rothwell PM, Slattery J, Warlow CP: A systematic review of the risk of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 1996;27:260–265.
22.
Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES: Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998;279:1278–1281.
23.
Ferguson GG, Eliasziw M, Barr HWK, et al, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1,415 patients. Stroke 1999;30:1751–1758.
24.
Bond R, Rerkasem K, Shearman CP, Rothwell PM: Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis 2004;18:37–46.
25.
Ouriel K, Shortell CK, Illig KA, Greenberg RK, Green RM: Intracerebral haemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg 1999;29:82–89.
26.
Adhiyaman V, Alexander S: Cerebral hyperperfusion syndrome following carotid endarterectomy. Q J Med 2007;100:239–244.
27.
Rothwell PM, Warlow CP, on behalf of the European Carotid Surgery Trialists’ Collaborative Group: Interpretation of operative risks of individual surgeons. Lancet 1999;353:1325.
28.
Kucey DS, Bowyer B, Iron K, Austin P, Anderson G, Tu JV: Determinants of outcome after carotid endarterectomy. J Vasc Surg 1998;28:1051–1058.
29.
Killeen SD, Andrews EJ, Redmond HP, Fulton GJ: Provider volume and outcomes for abdominal aortic aneurysm repair, carotid endarterectomy, and lower extremity revascularization procedures. J Vasc Surg 2007;45:615–626.
30.
Wong JH, Findlay JM, Suarez-Almazor ME: Regional performance of carotid endarterectomy: appropriateness, outcomes, and risk factors for complications. Stroke 1997;28:891–898.
31.
Naylor AR, Hayes PD, Allroggen H, Lennard N, Gaunt ME, Thompson MM, et al: Reducing the risk of carotid surgery: a 7-year audit of the role of monitoring and quality control assessment. J Vasc Surg 2000;32:750–759.
32.
Brittenden J, Bradbury AW: Are we still performing inappropriate carotid endarterectomy? Eur J Vasc Endovasc Surg 2000;20:158–162.
33.
Rothwell PM, Slattery J, Warlow CP: A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. Stroke 1996;27:266–269.
34.
Urbinati S, di Pasquale G, Andreoli A, et al: Preoperative noninvasive coronary risk stratification in candidates for carotid endarterectomy. Stroke 1994;25:2022–2027.
35.
Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: Medical complications associated with carotid endarterectomy. Stroke 1999;30:1759–1763.
36.
Cunningham EJ, Bond R, Mayberg MR, Warlow CP, Rothwell PM: Risk of persistent cranial nerve injury after carotid endarterectomy. J Neurosurg 2004;101:455–458.
37.
Rothwell PM: ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 2004;364:1122–1123.
38.
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM, for the Carotid Endarterectomy Trialists Collaboration: Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet 2004;363:915–924.
39.
Bond R, Rerkasem K, Cuffe R, Rothwell PM: A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 2005;20:69–77.
40.
Rothwell PM, Slattery J, Warlow CP: Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. Br Med J 1997;315:1571–1577.
41.
Pritz MB: Timing of carotid endarterectomy after stroke. Stroke 1997;28:2563–2567.
42.
Eckstein H, Schumacher H, Klemm K, et al: Emergency carotid endarterectomy. Cerebrovasc Dis 1999;9:270–281.
43.
Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study: Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 2004;62:569–674.
44.
Fairhead JF, Mehta Z, Rothwell PM: Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005;65:371–375.
45.
Blaser T, Hofmann K, Buerger T, Effenberger O, Wallesch C, Goertler M: Risk of stroke, transient ischaemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke 2002;33:1057–1062.
46.
Rothwell PM, Gutnikov SA, Eliasziw M, Warlow CP, Barnett HJM: Sex difference in effect of time from symptoms to surgery on benefit from endarterectomy for transient ischaemic attack and non-disabling stroke. Stroke 2004;35:2855–2861.
47.
Fairhead JF, Rothwell PM: The need for urgency in identification and treatment of symptomatic carotid stenosis is already established. Cerebrovasc Dis 2005;19:355–358.
48.
Rantner B, Pavelka M, Posch L, Schmidauer C, Fraedrich G: Carotid endarterectomy after ischemic stroke – Is there a justification for delayed surgery? Eur J Vasc Endovasc Surg 2005;30:36–40.
49.
Welsh S, Mead G, Chant H, Picton A, O’Neill PA, McCollum CN: Early carotid surgery in acute stroke: a multicentre randomized pilot study. Cerebrovasc Dis 2004;18:200–205.
50.
Pell JP, Slack R, Dennis M, Welch G: Improvements in carotid endarterectomy in Scotland: results of a national prospective survey. Scot Med J 2003;49:53–56.
51.
Rodgers H, Oliver SE, Dobson R, Thomson RG: A regional collaborative audit of the practice and outcome of carotid endarterectomy in the United Kingdom. Northern Regional Carotid Endarterectomy Audit Group. Eur J Vasc Endovasc Surg 2000;19:362–369.
52.
Turnbull RG, Taylor DC, Hsiang YN, Salvian AJ, Nanji S, O’Hanley G, Doyle DL, Fry PD: Assessment of patient waiting times for vascular surgery. Can J Surg 2000;43:105–111.
53.
Dotter CT, Judkins MP, Rosch J: Nonoperative treatment of arterial occlusive disease: a radiologically facilitated technique. Radiol Clin North Am 1967;5:531–542.
54.
Mathur A, Roubin GS, Iyer SS, et al: Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239–1245.
55.
McCabe DJH, Brown MM, Clifton A: Fatal cerebral reperfusion haemorrhage after carotid stenting. Stroke 1999;30:2483–2486.
56.
Qureshi AI, Luft AR, Sharma M, et al: Frequency and determinants of postprocedural haemodynamic instability after carotid angioplasty and stenting. Stroke 1999;30:2086–2093.
57.
Reimers B, Corvaja N, Moshiri S, et al: Cerebral protection with filter devices during carotid artery stenting. Circulation 2001;104:12–15.
58.
CAVATAS Investigators: Endovascular versus surgical treatment in patents with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729–1737.
59.
Naylor AR, Bolia A, Abbott RJ, et al: Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 1998;28:326–334.
60.
Alberts MJ, for the Publications Committee of the WALLSTENT: Results of a multicentre prospective randomised trial of carotid artery stenting vs carotid endarterectomy. Stroke 2001;32:325.
61.
Brooks WH, McClure RR, Jones MR, et al: Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001;38:1589–1595.
62.
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, et al: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.
63.
Coward LJ, Featherstone RL, Brown MM: Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 2005;36:905–911.
64.
SPACE Collaborative Group, Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W: 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239–1247.
65.
Mas JL, Chatellier G, Beyssen B, et al, for the EVA-3S Investigators: Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. NEJM 2006;355:1660–1671.
66.
Featherstone RL, Brown MM, Coward LJ: International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 2004;18:69–74.
67.
CaRESS Steering Committee: Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 2005;42:213–219.
68.
Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Stroke 2006;37:E36.
69.
Rothwell PM, Warlow CP, on behalf of the European Carotid Surgery Trialists’ Collaborative Group: Prediction of benefit from carotid endarterectomy in individual patients: a risk modeling study. Lancet 1999;353:2105–2110.
70.
Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP: From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet 2005;365:256–265.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.